Literature DB >> 18443374

Intensive glycemic control and cardiovascular disease observations from the ACCORD study: now what can a clinician possibly think?

William T Cefalu, Karol Watson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18443374     DOI： 10.2337/db08-0220

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  7 in total

1.  The ACCORD study: are any of the results truly in?

Authors:  Sharon D Jackson
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

2.  Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE).

Authors:  Urmimala Sarkar; Andrew J Karter; Jennifer Y Liu; Howard H Moffet; Nancy E Adler; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2010-05-18       Impact factor: 5.128

3.  Social behavioural epistemology and the scientific community.

Authors:  Milind Watve
Journal:  J Genet       Date:  2017-07       Impact factor: 1.166

Review 4.  The next generation of therapeutics for chronic kidney disease.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Nat Rev Drug Discov       Date:  2016-05-27       Impact factor: 84.694

Review 5.  Glycemic control and cardiovascular disease in chronic kidney disease.

Authors:  Suma Dronovalli; Basil O Burney; George L Bakris
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

6.  Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States.

Authors:  Kenneth G Saag; Penny E Mohr; Laura Esmail; Amy S Mudano; Nicole Wright; Timothy Beukelman; Jeffrey R Curtis; Gary Cutter; Elizabeth Delzell; Lisa C Gary; T Michael Harrington; Swapna Karkare; Meredith L Kilgore; Cora Elizabeth Lewis; Rachael Moloney; Ana Oliveira; Jasvinder A Singh; Amy Warriner; Jie Zhang; Marc Berger; Steven R Cummings; Wilson Pace; Daniel H Solomon; Robert Wallace; Sean R Tunis
Journal:  Contemp Clin Trials       Date:  2012-07-05       Impact factor: 2.226

7.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.